2008_The EMCDDA and the Reitox Network_towards Quality Achievment_slideshow_21p

7/28/2019 2008_The EMCDDA and the Reitox Network_towards Quality Achievment_slideshow_21p

1/21

The EMCDDA and the Reitox network:

towards quality achievement

Sandrine Sleiman, Scientific Committee, Palmela, February 2008
http://www.emcdda.europa.eu/


2/21

Contents

National focal points (NFP)

Operating framework

Challenges


3/21

What is a NFP?

An information interface between the Member State and the

EMCDDA. The NFPs play a double role:

National authority for providing national druginformation to

the EMCDDA (under national responsibility)

Ambassador of the EMCDDA at national level(under EMCDDA guidance)


4/21

Role of Reitox

Mechanism for collecting and exchanging

information between the EMCDDA and 30

countries:

27 EU Member States

Norway

2 candidate countries

European Commission


5/21

Prevention & Re-

habilitation ActivitiesCoordination Unit

The REITOX Network

Austrian Health

Institute

Scientific Institute

Public Health

National Board of

Health

National R&D Centre

for Welfare & Health

French Observatory

for Drugs & Drug

Addiction

Secretariat

Nat. Drug

Commission

Nat. Monitoring

Centre for Drugs

and Drug Addiction

State Centre

for Drug abusePrevention

Institute for

TherapyResearch

University Mental

Health ResearchInstitute

Health Research

Board

Estonian Drug

MonitoringCentre

Min. of Health

Nat. Centre forEpidemiology

Portuguese Institute

for Drugs & Drug

Addiction

Government Deleg.

to the National Plan

on Drugs

National Institute

of Public Health

Dept Min.

of Health

Nat. Bureau

for Drug

Prevention

Institute Public

Health

Board of Ministers

for Drug

Dependenciesand Drug Control

European

CommissionDirection de la

SantTrimbos Institute

SIRUSMin. of Health

Drug Control

Department

National

Commission for

Dependencies

National Centre

for AddictionsNational Anti-

Drugs Agency
http://www.emcdda.europa.eu/http://www.emcdda.europa.eu/http://www.crwflags.com/fotw/images/r/ro.gifhttp://www.crwflags.com/fotw/images/b/bg.gifhttp://www.crwflags.com/fotw/images/m/mt.gifhttp://www.crwflags.com/fotw/images/l/lt.gifhttp://www.crwflags.com/fotw/images/s/sk.gifhttp://www.crwflags.com/fotw/images/s/si.gifhttp://www.crwflags.com/fotw/images/p/pl.gifhttp://www.crwflags.com/fotw/images/h/hu.gifhttp://www.crwflags.com/fotw/images/e/ee.gifhttp://www.crwflags.com/fotw/images/l/lv.gifhttp://www.crwflags.com/fotw/images/c/cy.gifhttp://www.crwflags.com/fotw/images/c/cz.gifhttp://www.emcdda.europa.eu/


6/21

TurkeyTADOC Turkish Academy against Drugs

and Organised Crime

CroatiaOffice for Combating Narcotic Drug Abuse

The future new members of EMCDDA

And Western Balkan countries
http://www.crwflags.com/fotw/images/t/tr.gifhttp://www.33ff.com/flags/bandieremondo/bandiera_Croazia.htmlhttp://www.crwflags.com/fotw/images/t/tr.gifhttp://www.crwflags.com/fotw/images/t/tr.gifhttp://www.emcdda.europa.eu/


7/21

Basis for Reitox cooperation with NFPs

Founding Council Regulation of the EMCDDA

Operating framework for the Reitox system

New reporting structure and tools EMCDDA and Reitox work programmes

Grant agreements

Guidelines for reporting


8/21


9/21

Working towards a high-quality NFP

- institutional challenges

Institutional framework

Legal base

Clear mandate (incl. national responsibilities)

Validity period of NFP nomination

National political support

Evidence-based decision-making with regard

to drugs and drug addiction


10/21

Working towards a high-quality NFP

- operational challenges

NFP competences should mirror the EMCDDA

subject areas

Cooperation with national/regional druginformation network(s) and scientific community

Interagency cooperation

Access to national and regional data

Human and financial resources


11/21

The new Reitox operating framework

Result of a 2-y process: evaluation, working

group new operating framework, working

group new reporting tools Reporting tools

Grant agreement

Tasking process Capacity building


12/21

Guidelines for national reporting

Summary

Part A: New Developments and Trends1. National policies and context

2. Drug Use in the Population

3. Prevention

4. Problem Drug Use

5. Drug-Related Treatment

6. Health Correlates and Consequences

7. Responses to Health Correlates and Consequences

8. Social Correlates and Consequences

9. Responses to Social Correlates and Consequences

10. Drug Markets

Part B Selected Issues11. Sentencing statistics

Part C

14. Bibliography

15. Annexes


13/21

Outputs of REITOX cooperation

Information collected and analysed at

national level and submitted to the EMCDDA

National Reports, Structured Questionnaires, StandardTables

Implementation of the epidemiological key indicators

Data input into EMCDDA information systems

Early warnings on new synthetic drugs to the EMCDDA

Press clippings and replies to ad hoc requests


14/21

Reitox network challenges

Quality Assurance Policy

- Quality reports

- Implementation Needs Profiles

RTX Academy

- Motivating by supporting national needs

- Forging networking spirit


15/21

Data consistency

Quality check

Quality assessment

Process

Exploitation

Quality feedback


16/21

Since 2001 success

Generally recommendation for improvement

are applied regarding adherence to guidelines:

- General layout

- References to standard tables and structured questionnaires

- Sources and use of Harvard for bibliography- Methodological information

- Efforts in writting the National report


17/21

Gaps to fill in

Respect of deadline

Conciseness Weaknesses about lack of insight on trends

and interpretation of results

In some countries, it is still too early to have

many information on trends


18/21

2007 Reitox academies

Reitox Academy on cannabis prevention and treatment(29-30, March 2007)

Reitox Academy on public expenditure analysis in thefield of drugs (May (TBC), Luxembourg)

Reitox Academy Fonte training: introductory course(22nd May, heads of NFP meeting, Lisbon)

Reitox Academy Fonte training: specialised course

(8th, June, Ankara, Turkey)

Reitox Academy on science-based practices(12-13 Sep, Oslo, Norway)


19/21

2008 and beyond

RTX Academy on Media relations, TDI, analysis ofTDI data using different methodologies, qualitativeand quantitative and focus on data coverage.

Towards further improvements of the academies: to link more regularly RTX Academies with Selected Issues

to organise Academies for a broader audience (nationalexperts)

to provide with additional features (MP3 files)

updated strategy document on RTX Academy trainingprogramme


20/21

To participate in the RTX network and to

face challenges, usefulness and added

values of the network should be perceivedat national level


21/21

2008_The EMCDDA and the Reitox Network_towards Quality Achievment_slideshow_21p

Documents

Transcript of 2008_The EMCDDA and the Reitox Network_towards Quality Achievment_slideshow_21p